Risk of Coronavirus Disease 2019 Occurrence, Severe Presentation, and Mortality in Patients with Lung Cancer

被引:6
作者
Yang, Bumhee [1 ]
Choi, Hayoung [2 ]
Lee, Sun-Kyung [3 ,4 ]
Chung, Sung Jun [3 ]
Yeo, Yoomi [3 ]
Shin, Yoon Mi [1 ]
Park, Dong Won [3 ]
Park, Tai Sun [3 ]
Moon, Ji-Yong [3 ]
Kim, Tae-Hyung [3 ]
Sim, Yun Su [2 ]
Yoon, Ho Joo [3 ]
Sohn, Jang Won [3 ]
Lee, Hyun [3 ]
Kim, Sang-Heon [3 ]
机构
[1] Chungbuk Natl Univ, Chungbuk Natl Univ Hosp, Dept Med, Div Pulm & Crit Care Med,Coll Med, Cheongju, South Korea
[2] Hallym Univ, Kangnam Sacred Heart Hosp, Dept Internal Med, Div Pulm Allergy & Crit Care Med,Coll Med, Seoul, South Korea
[3] Hanyang Univ, Dept Internal Med, Div Pulm Med & Allergy, Coll Med, 222 Wangsimni Ro, Seoul 04763, South Korea
[4] Hanyang Univ, Coll Nat Sci, Dept Math, Seoul, South Korea
来源
CANCER RESEARCH AND TREATMENT | 2021年 / 53卷 / 03期
关键词
COVID-19; Lung neoplasms; Mortality; COVID-19;
D O I
10.4143/crt.2020.1242
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose This study aimed to analyze whether patients with lung cancer have a higher susceptibility of coronavirus disease 2019 (COVID-19), severe presentation, and higher mortality than those without lung cancer. Materials and Methods A nationwide cohort of confirmed COVID-19 (n=8,070) between January 1, 2020, and May 30, 2020, and a 1:15 age-, sex-, and residence-matched cohort (n=121,050) were constructed. A nested case-control study was performed to compare the proportion of patients with lung cancer between the COVID-19 cohort and the matched cohort. Results The proportion of patients with lung cancer was significantly higher in the COVID-19 cohort (0.5% [37/8,070]) than in the matched cohort (0.3% [325/121,050]) (p=0.002). The adjusted odds ratio [OR] of having lung cancer was significantly higher in the COVID-19 cohort than in the matched cohort (adjusted OR, 1.51; 95% confidence interval [CI], 1.05 to 2.10). Among patients in the COVID-19 cohort, compared to patients without lung cancer, those with lung cancer were more likely to have severe COVID-19 (54.1% vs. 13.2%, p < 0.001), including mortality (18.9% vs. 2.8%, p < 0.001). The adjusted OR for the occurrence of severe COVID-19 in patients with lung cancer relative to those without lung cancer was 2.24 (95% CI, 1.08 to 4.74). Conclusion The risk of COVID-19 occurrence and severe presentation, including mortality, may be higher in patients with lung cancer than in those without lung cancer.
引用
收藏
页码:678 / 684
页数:7
相关论文
共 17 条
[1]   Prevalence, Severity and Mortality associated with COPD and Smoking in patients with COVID-19: A Rapid Systematic Review and Meta-Analysis [J].
Alqahtani, Jaber S. ;
Oyelade, Tope ;
Aldhahir, Abdulelah M. ;
Alghamdi, Saeed M. ;
Almehmadi, Mater ;
Alqahtani, Abdullah S. ;
Quaderi, Shumonta ;
Mandal, Swapna ;
Hurst, John R. .
PLOS ONE, 2020, 15 (05)
[2]   Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study [J].
Chen, Nanshan ;
Zhou, Min ;
Dong, Xuan ;
Qu, Jieming ;
Gong, Fengyun ;
Han, Yang ;
Qiu, Yang ;
Wang, Jingli ;
Liu, Ying ;
Wei, Yuan ;
Xia, Jia'an ;
Yu, Ting ;
Zhang, Xinxin ;
Zhang, Li .
LANCET, 2020, 395 (10223) :507-513
[3]   Population-based prevalence of bronchiectasis and associated comorbidities in South Korea [J].
Choi, Hayoung ;
Yang, Bumhee ;
Nam, Hyewon ;
Kyoung, Dae-Sung ;
Sim, Yun Su ;
Park, Hye Yun ;
Lee, Jae Seung ;
Lee, Sei Won ;
Oh, Yeon-Mok ;
Ra, Seung Won ;
Kim, Sang-Heon ;
Sohn, Jang Won ;
Yoon, Ho Joo ;
Lee, Hyun .
EUROPEAN RESPIRATORY JOURNAL, 2019, 54 (02)
[4]   COVID-19 in patients with thoracic malignancies (TERAVOLT): first results of an international, registry-based, cohort study [J].
Garassino, Marina Chiara ;
Whisenant, Jennifer G. ;
Huang, Li-Ching ;
Trama, Annalisa ;
Torri, Valter ;
Agustoni, Francesco ;
Baena, Javier ;
Banna, Giuseppe ;
Berardi, Rossana ;
Bettini, Anna Cecilia ;
Bria, Emilio ;
Brighenti, Matteo ;
Cadranel, Jacques ;
De Toma, Alessandro ;
Chini, Claudio ;
Cortellini, Alessio ;
Felip, Enriqueta ;
Finocchiaro, Giovanna ;
Garrido, Pilar ;
Genova, Carlo ;
Giusti, Raffaele ;
Gregorc, Vanesa ;
Grossi, Francesco ;
Grosso, Federica ;
Intagliata, Salvatore ;
La Verde, Nicla ;
Liu, Stephen, V ;
Mazieres, Julien ;
Mercadante, Edoardo ;
Michielin, Olivier ;
Minuti, Gabriele ;
Moro-Sibilot, Denis ;
Pasello, Giulia ;
Passaro, Antonio ;
Scotti, Vieri ;
Solli, Piergiorgio ;
Stroppa, Elisa ;
Tiseo, Marcello ;
Viscardi, Giuseppe ;
Voltolini, Luca ;
Wu, Yi-Long ;
Zai, Silvia ;
Pancaldi, Vera ;
Dingemans, Anne-Marie ;
Van Meerbeeck, Jan ;
Barlesi, Fabrice ;
Wakelee, Heather ;
Peters, Solange ;
Horn, Leora .
LANCET ONCOLOGY, 2020, 21 (07) :914-922
[5]   Baseline Characteristics and Outcomes of 1591 Patients Infected With SARS-CoV-2 Admitted to ICUs of the Lombardy Region, Italy [J].
Grasselli, Giacomo ;
Zangrillo, Alberto ;
Zanella, Alberto ;
Antonelli, Massimo ;
Cabrini, Luca ;
Castelli, Antonio ;
Cereda, Danilo ;
Coluccello, Antonio ;
Foti, Giuseppe ;
Fumagalli, Roberto ;
Iotti, Giorgio ;
Latronico, Nicola ;
Lorini, Luca ;
Merler, Stefano ;
Natalini, Giuseppe ;
Piatti, Alessandra ;
Ranieri, Marco Vito ;
Scandroglio, Anna Mara ;
Storti, Enrico ;
Cecconi, Maurizio ;
Pesenti, Antonio .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2020, 323 (16) :1574-1581
[6]   Critical Care Utilization for the COVID-19 Outbreak in Lombardy, Italy Early Experience and Forecast During an Emergency Response [J].
Grasselli, Giacomo ;
Pesenti, Antonio ;
Cecconi, Maurizio .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2020, 323 (16) :1545-1546
[7]   Clinical Characteristics of Coronavirus Disease 2019 in China [J].
Guan, W. ;
Ni, Z. ;
Hu, Yu ;
Liang, W. ;
Ou, C. ;
He, J. ;
Liu, L. ;
Shan, H. ;
Lei, C. ;
Hui, D. S. C. ;
Du, B. ;
Li, L. ;
Zeng, G. ;
Yuen, K. -Y. ;
Chen, R. ;
Tang, C. ;
Wang, T. ;
Chen, P. ;
Xiang, J. ;
Li, S. ;
Wang, Jin-lin ;
Liang, Z. ;
Peng, Y. ;
Wei, L. ;
Liu, Y. ;
Hu, Ya-hua ;
Peng, P. ;
Wang, Jian-ming ;
Liu, J. ;
Chen, Z. ;
Li, G. ;
Zheng, Z. ;
Qiu, S. ;
Luo, J. ;
Ye, C. ;
Zhu, S. ;
Zhong, N. .
NEW ENGLAND JOURNAL OF MEDICINE, 2020, 382 (18) :1708-1720
[8]   Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China [J].
Liang, Wenhua ;
Guan, Weijie ;
Chen, Ruchong ;
Wang, Wei ;
Li, Jianfu ;
Xu, Ke ;
Li, Caichen ;
Ai, Qing ;
Lu, Weixiang ;
Liang, Hengrui ;
Li, Shiyue ;
He, Jianxing .
LANCET ONCOLOGY, 2020, 21 (03) :335-337
[9]   COVID-19 in patients with lung cancer [J].
Luo, J. ;
Rizvi, H. ;
Preeshagul, I. R. ;
Egger, J., V ;
Hoyos, D. ;
Bandlamudi, C. ;
McCarthy, C. G. ;
Falcon, C. J. ;
Schoenfeld, A. J. ;
Arbour, K. C. ;
Chaft, J. E. ;
Daly, R. M. ;
Drilon, A. ;
Eng, J. ;
Iqbal, A. ;
Lai, W., V ;
Li, B. T. ;
Lito, P. ;
Namakydoust, A. ;
Ng, K. ;
Offin, M. ;
Paik, P. K. ;
Riely, G. J. ;
Rudin, C. M. ;
Yu, H. A. ;
Zauderer, M. G. ;
Donoghue, M. T. A. ;
Luksza, M. ;
Greenbaum, B. D. ;
Kris, M. G. ;
Hellmann, M. D. .
ANNALS OF ONCOLOGY, 2020, 31 (10) :1386-1396
[10]   Renin-Angiotensin-Aldosterone System Inhibitors and Risk of Covid-19 [J].
Reynolds, Harmony R. ;
Adhikari, Samrachana ;
Pulgarin, Claudia ;
Troxel, Andrea B. ;
Iturrate, Eduardo ;
Johnson, Stephen B. ;
Hausvater, Anais ;
Newman, Jonathan D. ;
Berger, Jeffrey S. ;
Bangalore, Sripal ;
Katz, Stuart D. ;
Fishman, Glenn I. ;
Kunichoff, Dennis ;
Chen, Yu ;
Ogedegbe, Gbenga ;
Hochman, Judith S. .
NEW ENGLAND JOURNAL OF MEDICINE, 2020, 382 (25) :2441-2448